Early changes in biochemical markers of bone formation during teriparatide therapy correlate with improvements in vertebral strength in men with glucocorticoid-induced osteoporosis.
Farahmand P, Marin F, Hawkins F, Möricke R, Ringe JD, Glüer CC, Papaioannou N, Minisola S, Martínez G, Nolla JM, Niedhart C, Guañabens N, Nuti R, Martín-Mola E, Thomasius F, Peña J, Graeff C, Kapetanos G, Petto H, Gentzel A, Reisinger A, Zysset PK.
Farahmand P, et al. Among authors: papaioannou n.
Osteoporos Int. 2013 Dec;24(12):2971-81. doi: 10.1007/s00198-013-2379-5. Epub 2013 Jun 6.
Osteoporos Int. 2013.
PMID: 23740422
Free PMC article.
Clinical Trial.